Identification of Novel Fibrosis Modifiers by In Vivo siRNA Silencing

Fibrotic diseases contribute to 45% of deaths in the industrialized world, and therefore a better understanding of the pathophysiological mechanisms underlying tissue fibrosis is sorely needed. We aimed to identify novel modifiers of tissue fibrosis expressed by myofibroblasts and their progenitors...

Descripción completa

Detalles Bibliográficos
Autores principales: Vollmann, Elisabeth H., Cao, Lizhi, Amatucci, Aldo, Reynolds, Taylor, Hamann, Stefan, Dalkilic-Liddle, Isin, Cameron, Thomas O., Hossbach, Markus, Kauffman, Kevin J., Mir, Faryal F., Anderson, Daniel G., Novobrantseva, Tatiana, Koteliansky, Victor, Kisseleva, Tatiana, Brenner, David, Duffield, Jeremy, Burkly, Linda C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424569/
https://www.ncbi.nlm.nih.gov/pubmed/28624207
http://dx.doi.org/10.1016/j.omtn.2017.04.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424569/
https://www.ncbi.nlm.nih.gov/pubmed/28624207
http://dx.doi.org/10.1016/j.omtn.2017.04.014

Ejemplares similares